Importantly, our human study demonstrated that SLC26A4 expression was increased in AT2 cells of asthmatic patients, and demonstrated for the first time to our knowledge that serum levels of SLC26A4 were much higher in patients with mild and severe asthma compared with healthy controls. This evidence concerns the gene SLC26A4 and asthma.